Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report 2025-2030, Featuring Laboratory Corporation of America, IQVIA, Syneous Health, SGS, WuXi AppTec and Other Major Players
02 déc. 2024 04h56 HE
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis, 2025-2030" report has been added to ResearchAndMarkets.com's...
Incannex Receives Ethics Approval for Bioequivalence/Bioavailability Clinical Trial for IHL-42X, the Company’s Proprietary Drug for Treatment of Obstructive Sleep Apnoea (‘OSA’)
06 juil. 2023 08h42 HE
|
Incannex Healthcare
Highlights: Incannex has received approval from Bellberry Human Research Ethics Committee (‘HREC’) to commence the bioavailability/bioequivalence (‘BA/BE’) clinical trial to assess the...
Global Large Molecule Bioanalytical Testing Services Market Report 2022 to 2029: Featuring Charles River, Medpace, WuXi AppTec and Eurofins Scientific Among Others
01 déc. 2022 06h33 HE
|
Research and Markets
Dublin, Dec. 01, 2022 (GLOBE NEWSWIRE) -- The "Large Molecule Bioanalytical Testing Services Market Analysis by Phase, by Type, by Test Type, by Therapeutic Area, by End user by Region - Global...
Global Bioanalytical Testing Services Market (2022 to 2030) - Size, Share & Trends Analysis Report
22 févr. 2022 07h23 HE
|
Research and Markets
Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Molecule (Small, Large), by Test (Bioavailability, Bioequivalance),...
Global $6.34 Bn Bioanalytical Testing Services Markets to 2028 - Increasing Outsourcing Services & Rising Investments in the Sector
23 nov. 2021 05h28 HE
|
Research and Markets
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Bioanalytical Testing Services Market Share, Size, Trends, Industry Analysis Report, By Molecule Type (Small Molecule, Large Molecule); By Test Type;...
Minerva Neurosciences Announces Study Results Demonstrating Bioequivalence of Phase 2b, Phase 3, and Planned Commercial Formulations of Roluperidone for Treatment of Negative Symptoms of Schizophrenia
30 sept. 2021 08h30 HE
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...
Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation
20 sept. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the Company has been awarded a grant from the U.S. Food and Drug...
Global Large Molecule Bioanalytical Testing Services Market Report 2021: Increased Applications in Clinical Trials of Biomarkers & Large Molecules
24 août 2021 08h13 HE
|
Research and Markets
Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Phase (Preclinical, Clinical), by Test Type...
Elite Pharmaceuticals Reports Positive Topline Results from Pivotal Bioequivalence Studies for an Extended-Release Generic
10 janv. 2018 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies for...
Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200
05 mars 2014 07h30 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today successful results from a pivotal bioequivalence study initiated...